Sleep apnoea and the heart

Patrick Lévy, Silke Ryan, Olaf Oldenburg, Gianfranco Parati

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Sleep apnoea is associated with significant daytime functioning impairment and marked cardiovascular morbidities, leading to a significant increase in mortality. Sympathetic activation, oxidative stress and systemic inflammation have been shown to be the main intermediary mechanisms associated with sleep apnoea and intermittent hypoxia. There are now convincing data regarding the association between hypertension, arrhythmias, coronary heart disease, heart failure, increased cardiovascular mortality and sleep apnoea. This has been evidenced in sleep apnoea patients and is supported by experimental data obtained in intermittent hypoxia. Whether treating sleep apnoea enables chronic cardiovascular consequences to be reversed is not fully established as regard coronary heart disease, arrhythmias and heart failure. In this late condition, complex bidirectional relationships occur, with obstructive sleep apnoea being a risk factor for heart failure whilst central sleep apnoea mainly appears as a consequence of heart failure. It remains to be established in adequately designed studies, i.e. large randomised controlled trials, whether treating sleep apnoea can improve heart failure morbidity and mortality.

Original languageEnglish
Pages (from-to)333-352
Number of pages20
JournalEuropean Respiratory Review
Volume22
Issue number129
DOIs
Publication statusPublished - Oct 1 2013

Fingerprint

Sleep Apnea Syndromes
Heart Failure
Coronary Disease
Mortality
Cardiac Arrhythmias
Central Sleep Apnea
Morbidity
Obstructive Sleep Apnea
Oxidative Stress
Randomized Controlled Trials
Hypertension
Inflammation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Sleep apnoea and the heart. / Lévy, Patrick; Ryan, Silke; Oldenburg, Olaf; Parati, Gianfranco.

In: European Respiratory Review, Vol. 22, No. 129, 01.10.2013, p. 333-352.

Research output: Contribution to journalArticle

Lévy, P, Ryan, S, Oldenburg, O & Parati, G 2013, 'Sleep apnoea and the heart', European Respiratory Review, vol. 22, no. 129, pp. 333-352. https://doi.org/10.1183/09059180.00004513
Lévy, Patrick ; Ryan, Silke ; Oldenburg, Olaf ; Parati, Gianfranco. / Sleep apnoea and the heart. In: European Respiratory Review. 2013 ; Vol. 22, No. 129. pp. 333-352.
@article{5232ca740208489f948d493678bcb0d3,
title = "Sleep apnoea and the heart",
abstract = "Sleep apnoea is associated with significant daytime functioning impairment and marked cardiovascular morbidities, leading to a significant increase in mortality. Sympathetic activation, oxidative stress and systemic inflammation have been shown to be the main intermediary mechanisms associated with sleep apnoea and intermittent hypoxia. There are now convincing data regarding the association between hypertension, arrhythmias, coronary heart disease, heart failure, increased cardiovascular mortality and sleep apnoea. This has been evidenced in sleep apnoea patients and is supported by experimental data obtained in intermittent hypoxia. Whether treating sleep apnoea enables chronic cardiovascular consequences to be reversed is not fully established as regard coronary heart disease, arrhythmias and heart failure. In this late condition, complex bidirectional relationships occur, with obstructive sleep apnoea being a risk factor for heart failure whilst central sleep apnoea mainly appears as a consequence of heart failure. It remains to be established in adequately designed studies, i.e. large randomised controlled trials, whether treating sleep apnoea can improve heart failure morbidity and mortality.",
author = "Patrick L{\'e}vy and Silke Ryan and Olaf Oldenburg and Gianfranco Parati",
year = "2013",
month = "10",
day = "1",
doi = "10.1183/09059180.00004513",
language = "English",
volume = "22",
pages = "333--352",
journal = "European Respiratory Review",
issn = "0905-9180",
publisher = "European Respiratory Society",
number = "129",

}

TY - JOUR

T1 - Sleep apnoea and the heart

AU - Lévy, Patrick

AU - Ryan, Silke

AU - Oldenburg, Olaf

AU - Parati, Gianfranco

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Sleep apnoea is associated with significant daytime functioning impairment and marked cardiovascular morbidities, leading to a significant increase in mortality. Sympathetic activation, oxidative stress and systemic inflammation have been shown to be the main intermediary mechanisms associated with sleep apnoea and intermittent hypoxia. There are now convincing data regarding the association between hypertension, arrhythmias, coronary heart disease, heart failure, increased cardiovascular mortality and sleep apnoea. This has been evidenced in sleep apnoea patients and is supported by experimental data obtained in intermittent hypoxia. Whether treating sleep apnoea enables chronic cardiovascular consequences to be reversed is not fully established as regard coronary heart disease, arrhythmias and heart failure. In this late condition, complex bidirectional relationships occur, with obstructive sleep apnoea being a risk factor for heart failure whilst central sleep apnoea mainly appears as a consequence of heart failure. It remains to be established in adequately designed studies, i.e. large randomised controlled trials, whether treating sleep apnoea can improve heart failure morbidity and mortality.

AB - Sleep apnoea is associated with significant daytime functioning impairment and marked cardiovascular morbidities, leading to a significant increase in mortality. Sympathetic activation, oxidative stress and systemic inflammation have been shown to be the main intermediary mechanisms associated with sleep apnoea and intermittent hypoxia. There are now convincing data regarding the association between hypertension, arrhythmias, coronary heart disease, heart failure, increased cardiovascular mortality and sleep apnoea. This has been evidenced in sleep apnoea patients and is supported by experimental data obtained in intermittent hypoxia. Whether treating sleep apnoea enables chronic cardiovascular consequences to be reversed is not fully established as regard coronary heart disease, arrhythmias and heart failure. In this late condition, complex bidirectional relationships occur, with obstructive sleep apnoea being a risk factor for heart failure whilst central sleep apnoea mainly appears as a consequence of heart failure. It remains to be established in adequately designed studies, i.e. large randomised controlled trials, whether treating sleep apnoea can improve heart failure morbidity and mortality.

UR - http://www.scopus.com/inward/record.url?scp=84883319758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883319758&partnerID=8YFLogxK

U2 - 10.1183/09059180.00004513

DO - 10.1183/09059180.00004513

M3 - Article

C2 - 23997061

AN - SCOPUS:84883319758

VL - 22

SP - 333

EP - 352

JO - European Respiratory Review

JF - European Respiratory Review

SN - 0905-9180

IS - 129

ER -